Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Iron Complex. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101412738A details a novel iron-catalyzed asymmetric O-H insertion. This technology offers cost-effective, high-enantioselectivity routes for API intermediates.
Novel iron-catalyzed asymmetric hydrogenation using chiral quinoline imidazoline ligands offers high enantioselectivity and cost-effective alternatives to noble metals for pharmaceutical intermediates.